Do patents prevent access to drugs for HIV in developing countries?
Boelaert, M.; Lynen, L.; Van Damme, W.; Colebunders, R.
JAMA 287(7): 840
2002
ISSN/ISBN: 0098-7484 PMID: 11851568 Document Number: 549429
Document emailed within 1 workday
Related Documents
Goemaere, E.; Kaninda, A-Valerie.; Ciaffi, L.; Mulemba, M.; t Hoen, E.; Pécoul, B. 2002: Do patents prevent access to drugs for HIV in developing countries? JAMA 287(7): 841Borrell, J. 2007: Pricing and patents of HIV/AIDS drugs in developing countries Applied Economics 39(4): 505-518
Borrell, J. 2007: Pricing and patents of HIV/AIDS drugs in developing countries Applied Economics 39(4): 505-518
Borrell, J. 2005: Patents and the faster introduction of new drugs in developing countries Applied Economics Letters 12(6): 379-382
Spira, S.C.; Wainberg, M.A. 2004: Jewish religious ethics mandate access to antiretroviral drugs in developing countries Journal of the International Association of Physicians in Aids Care 3(1): 7-11
Van der Stuyft, P.; Boelaert, M.; Temmerman, M. 1998: Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions? Tropical Medicine and International Health: Tm and Ih 3(9): 689-690
Ellertson, C.; Winikoff, B.; Armstrong, E.; Camp, S.; Senanayake, P. 1995: Expanding access to emergency contraception in developing countries Studies in Family Planning 26(5): 251-263
Elliott, R. 2002: WHO initiatives to increase access to treatment in developing countries Canadian Hiv/Aids Policy and Law Review 7(2-3): 57-58
Klug, H. 2008: Law, Politics, and Access to Essential Medicines in Developing Countries Politics-Society 36(2): 207-245
Schoen Angerer, T. von; Wilson, D.; Ford, N.; Kasper, T. 2001: Access and activism: the ethics of providing antiretroviral therapy in developing countries AIDS 15(Suppl 5): S81-S90
Shah, S.; Elmer, S.; Grady, C. 2009: Planning for Posttrial Access to Antiretroviral Treatment for Research Participants in Developing Countries American Journal of Public Health (1971) 99(9): 1556-1562
Schüklenk, U.; Ashcroft, R.E. 2002: Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives Journal of Medicine and Philosophy 27(2): 179-195
2005: Access to HIV treatment continues to accelerate in developing countries, but bottlenecks persist, says WHO/UNAIDS report Indian Journal of Medical Sciences 59(7): 323-326
Sturchio, J.L. 2001: The case of ivermectin: lessons and implications for improving access to care and treatment in developing countries Community Eye Health 14(38): 22-23
Moon, S.; Jambert, E.; Childs, M.; von Schoen-Angerer, T. 2011: A win-win solution?: a critical analysis of tiered pricing to improve access to medicines in developing countries Globalization and Health 7: 39
Brower, V. 1997: UNAIDS expands HIV drug access in developing countries. Joint United Nations Programme on HIV/AIDS Nature Medicine 3(12): 1307
Sarna, A.; Kellerman, S. 2010: Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008 Public Health Reports 125(2): 305-315
Jallow, M.T.; Lunde, P.K. 1991: Drugs in developing countries. Current status, problems and possible solutions Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(16): 1960-1967
Walter V Reid; José Goldemberg 1998: Developing countries are combating climate change: Actions in developing countries that slow growth in carbon emissions Energy Policy 26(3): 233-237
Drake, P.M.W.; Thangaraj, H. 2010: Molecular farming, patents and access to medicines Expert Review of Vaccines 9(8): 811-819